Nuvation Bio Inc. NUVB
4.69 USD +0.10 (+2.18%)
At closeNov 4, 2026, 7:46 AM EST
4.73 +0.04 +0.85%
Pre-market · Nov 4, 7:46 AM ET
4.61 Day range 4.79
4.05 52-week range 9.75
- YTD
- -47.66%
- 1 year
- -2.90%
Financial health
Altman Z-Score
0.49 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -14.9×
FY 2018 5y median -4.3× FY 2025
P/S 48.7×
FY 2018 5y median 0.0× FY 2025
P/B 10.0×
FY 2018 5y median 1.5× FY 2025
P/FCF -17.6×
FY 2018 5y median -5.5× FY 2025
EV/EBITDA -15.4×
FY 2018 5y median -3.9× FY 2025
EV/Sales 46.2×
FY 2018 5y median 0.0× FY 2025
FCF Yield -5.7%
FY 2018 5y median -18.3% FY 2025
Profitability
Gross Margin 86.6%
FY 2018 5y median 0.0% FY 2025
Operating Margin -338.7%
FY 2018 5y median 0.0% FY 2025
Net Margin -325.3%
FY 2018 5y median 0.0% FY 2025
ROE -66.9%
FY 2018 5y median -15.9% FY 2025
ROIC -41.0%
FY 2018 5y median -18.1% FY 2025
ROA -34.4%
FY 2018 5y median -15.5% FY 2025
Growth (YoY)
Revenue 699.0%
FY 2018 FY 2025
Operating Income 64.0%
FY 2018 FY 2025
EPS (diluted) 71.6%
FY 2018 FY 2025
Free Cash Flow -33.1%
FY 2018 FY 2025
Financial Health
Current Ratio 7.0×
FY 2018 5y median 44.1× FY 2025
Quick Ratio 6.8×
FY 2018 5y median 44.1× FY 2025
Debt / Equity 0.0×
FY 2018 5y median 0.0× FY 2025
Net Debt / EBITDA 0.8×
FY 2018 5y median 0.8× FY 2025
Interest Coverage -15.6×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31